sorafenib,bevacizumab,atezolizumab
roche
['gi ', 'imbrave150', 'atezo', 'hcc']
my poster #asco23 on efficacy &amp; bleeding events with atezo+bev in #hcc pts n=112 comparable os,pfs and rr to imbrave150 70% egd uptake gi bleed rate 5% gi bleed in egd vs non-egd: 6% vs 3% difference os &amp; pfs in pts with bleeding vs no bleeding ?? selective egd 
Med Onc Fellow @pmcancercentre. Special focus #pancreaticcancer, #hepatobiliarycancer & #colorectalcancer. I was early taught to work as well as play!